|
Market Closed -
Euronext Paris
11:55:00 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 71.82 EUR | +1.53% |
|
+1.71% | -13.18% |
| 10-14 | Health Care Up as Health Insurer Rebound Continues - Health Care Roundup | DJ |
| 10-14 | European Stocks Close Higher Wednesday as Investors Parse Earnings | MT |
| Market Cap | 86.05B 96.23B 80.15B 72.8B 137B 9,134B 138B 962B 376B 4,758B 361B 353B 15,209B | P/E 2026 * |
11.7x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 97.38B 109B 90.7B 82.39B 155B 10,337B 156B 1,089B 426B 5,385B 408B 400B 17,212B | EV / Sales 2026 * |
2.06x | EV / Sales 2027 * | 1.86x |
| Free-Float |
88.34% | Yield 2026 * |
5.93% | Yield 2027 * | 6.27% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| SAN | Real-time | |
CBOE
| SAN | Real-time | |
|
London S.E.
| 0O59 | Delayed | |
|
Xetra
| SNW | Delayed | |
|
Tradegate
| SNW | Real-time | |
|
Borsa Italiana
| 1SAN | End-of-day quote | |
|
Boerse Muenchen
| SNW | Real-time | |
|
Deutsche Boerse AG
| SNW | Delayed | |
|
OTC Markets
| SNYNF | Delayed | |
|
Börse Stuttgart
| SNW | Delayed | |
|
Bulgaria S.E.
| SNW | End-of-day quote | |
|
Wiener Boerse
| SANO | End-of-day quote | |
|
CBOE
| 0O59 | Real-time | |
|
Swiss Exchange
| SAN | Delayed |
Last Transcript: Sanofi
| 1 day | +1.53% | ||
| 1 week | +1.71% | ||
| Current month | -1.13% | ||
| 1 month | -1.97% | ||
| 3 months | -6.85% | ||
| 6 months | -9.56% | ||
| Current year | -13.18% |
| 1 week | 70.1 |  | 72.76 |
| 1 month | 69.75 | | 75.34 |
| Current year | 69.75 | | 84.97 |
| 1 year | 69.75 | | 91.15 |
| 3 years | 69.75 | | 110.88 |
| 5 years | 69.75 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 56 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 | Buy | Chief Executive Officer | 1,506 | 0.0001% | ||
| 8/20/26 | Buy | Head of Human Resources | 54 | 0.0000% | ||
| 8/20/26 | Buy | Executive/Senior Manager | 840 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.53% | +1.71% | -14.66% | -30.53% | 94.87B | |
| +3.62% | +4.43% | +47.52% | +98.41% | 1,040B | |
| +2.13% | -0.34% | +33.01% | +61.88% | 599B | |
| +3.32% | +6.30% | +23.09% | +91.59% | 485B | |
| +3.80% | +3.83% | +71.96% | +41.69% | 350B | |
| +3.09% | +6.03% | +27.85% | +45.42% | 345B | |
| +2.82% | +4.68% | +17.38% | +40.15% | 272B | |
| +3.40% | +2.86% | -3.33% | +12.08% | 244B | |
| +3.21% | +5.84% | +45.73% | +49.99% | 223B | |
| +3.80% | +6.45% | +29.89% | +97.73% | 183B | |
| Average | +1.76% | +2.16% | +27.84% | +50.84% | 383.77B | |
| Weighted average by Cap. | +1.44% | +2.26% | +34.77% | +66.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.37B 52.98B 44.12B 40.08B 75.31B 5,029B 75.94B 530B 207B 2,620B 199B 194B 8,373B | 50.47B 56.45B 47.01B 42.7B 80.24B 5,358B 80.92B 564B 221B 2,791B 212B 207B 8,921B |
| Net income | 7.3B 8.16B 6.8B 6.17B 11.6B 775B 11.7B 81.58B 31.89B 404B 30.61B 29.94B 1,290B | 8.81B 9.86B 8.21B 7.46B 14.01B 936B 14.13B 98.53B 38.52B 487B 36.97B 36.16B 1,558B |
| Net Debt | 11.34B 12.68B 10.56B 9.59B 18.02B 1,203B 18.17B 127B 49.54B 627B 47.54B 46.51B 2,004B | 8B 8.95B 7.45B 6.77B 12.72B 850B 12.83B 89.47B 34.98B 443B 33.57B 32.84B 1,415B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-14 | €71.82 | +1.53% | 3,222,320 |
| 26-10-13 | €70.74 | -1.20% | 2,306,896 |
| 26-10-12 | €71.60 | +0.11% | 1,843,195 |
| 26-10-09 | €71.52 | +0.83% | 1,832,721 |
| 26-10-08 | €70.93 | -1.23% | 2,089,278 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
